What does Invivyd, Inc. do?

Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the…

What is Invivyd, Inc.'s P/E and P/B ratio?

Invivyd, Inc. has a P/E ratio of -1.8 and a P/B ratio of 0.99.

What is Invivyd, Inc.'s debt-to-equity ratio?

Invivyd, Inc. has a debt-to-equity ratio of 0.05.

How much does Invivyd, Inc. owe compared with what it owns?

Invivyd, Inc. owes $0.17 for every $1 it owns (balance sheet Jun 2026), which is low.

Does Invivyd, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Invivyd, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 24 Jul 2026). It has no yellow flags.

Where can I read the latest news about Invivyd, Inc.?

Recent headlines about Invivyd, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Invivyd, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Invivyd, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

Invivyd, Inc.

Q: What is Invivyd, Inc.'s Positivity rank?

Invivyd, Inc. is ranked #3,002 of 6,774 companies globally and #1,149 of 4,000 in United States on PositoAI, with a Positivity Score of 20,948.

NasdaqGM: IVVD · Healthcare

Positivity Index

#3,002 / 6,774

Global

#1,149 / 4,000

United States

Positivity Score

20,948

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 24 Jul 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Invivyd, Inc. — Overview & Financial Snapshot

Invivyd, Inc. (NasdaqGM: IVVD) is a Healthcare company, ranked #3,002 of 6,774 companies globally and #1,149 of 4,000 in United States on PositoAI, with a Positivity Score of 20,948. Its market capitalisation is ₹1,697.45 Cr ($179.83M), P/E ratio is -1.8 and P/B ratio is 0.99. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →